$CELG Company News The market puts a few feathers in its

New Post Public Reply Private Reply Replies (0) Message Board

Jan 25, 2014 at 1:56 PM

$CELG Company News

The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 12:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Epizyme shares surge 65% after cancer therapy hits milestone 11:06 a.m. Jan. 7, 2014 - Russ Britt
Sirius soars; Twitter tumbles on downgrade 3:50 p.m. Jan. 6, 2014 - Wallace Witkowski
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Sorry, haters: Unloved stocks had a great year 7:41 a.m. Dec. 30, 2013 - Brett Arends
These S&P winners have room to grow in 2014 6:00 a.m. Dec. 23, 2013 - Jeff Reeves
Two growth stocks that look ready to fly 1:29 p.m. Dec. 12, 2013 - The Trading Deck
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
What the worst advisers are recommending 1:16 p.m. Nov. 21, 2013 - Mark Hulbert
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Celgene raises earnings outlook as sales climb 7:27 a.m. Oct. 24, 2013 - MarketWatch.com
A bull market as typical as any other 11:23 a.m. Oct. 22, 2013 - The Trading Deck
No shortcut to innovation 7:30 a.m. Oct. 2, 2013 - Mark Hulbert
Market uptrend bends, without cracking 11:55 a.m. Oct. 1, 2013 - Michael Ashbaugh
Market technicals bend, without cracking 11:38 a.m. Oct. 1, 2013 - Michael Ashbaugh
Of keg parties and Big Ben 11:29 a.m. Sept. 19, 2013 - The Trading Deck

Celgene Corporation (CELG): Today's Featured Health Care Laggard 5:01 p.m. Jan. 24, 2014 - TheStreet.com
Is There A Rally Ahead For Healthcare Stocks After Bristol Meyers Beat Earnings? 4:58 p.m. Jan. 24, 2014 - TheStreet.com
Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press! 3:40 p.m. Jan. 24, 2014 - TheStreet.com
Cramer's Mad Money - It's All About Icahn (1/23/14) 5:56 a.m. Jan. 24, 2014 - Seeking Alpha
3 Biotechs to Buy and 1 to Sell Now 5:29 a.m. Jan. 24, 2014 - InvestorPlace.com
Interesting CELG Put And Call Options For February 28th 12:03 p.m. Jan. 23, 2014 - TheStreet.com
Biotech Bull Market Key Trend No. 1: 5 Large Cap Biopharmas Plus 2 11:39 a.m. Jan. 23, 2014 - Seeking Alpha
Pending Buy Signal Should Propel This Biotech to My Target 7:32 p.m. Jan. 22, 2014 - InvestorPlace.com
Cowen names its top biotech stocks with biggest upside to buy in 2014 6:45 p.m. Jan. 22, 2014 - Seeking Alpha
First Week Of March 22nd Options Trading For Celgene (CELG) 1:03 p.m. Jan. 22, 2014 - TheStreet.com
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
5 Drugs Stocks Nudging The Industry Higher 12:03 p.m. Jan. 22, 2014 - TheStreet.com
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside 8:54 a.m. Jan. 22, 2014 - 247WallSt.com
Celgene to Report Q4 FY 2013 Results on January 30, 2014, Before the Market Open 7:34 a.m. Jan. 22, 2014 - benzinga.com
Winners In 2013 Showed Fast Recent EPS Growth 4:18 p.m. Jan. 21, 2014 - Investors Business Daily
Some of 2013's Best Performing Stocks Look Good for 2014 2:25 p.m. Jan. 21, 2014 - benzinga.com
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry 7:19 a.m. Jan. 21, 2014 - Seeking Alpha
Positive Oncology News Lifts OncoMed - Analyst Blog 5:10 p.m. Jan. 20, 2014 - Zacks.com
Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily

Celgene Corporation to Announce Fourth Quarter and Full Year 2013 Results on January 30, 2014 8:30 a.m. Jan. 22, 2014 - BusinessWire - BZX
Celgene Corporation Announces 2014 Financial Outlook and Preliminary 2013 Results 11:29 a.m. Jan. 13, 2014 - BusinessWire - BZX
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Jan. 7, 2014 - PR Newswire
ABRAXANE(R) Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer 6:01 a.m. Jan. 7, 2014 - BusinessWire
Critical Alerts For Google, Celgene, Salesforce.com, Chesapeake Energy, and Endo Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 3, 2014 - PR Newswire
Celgene Corporation to Present at the 32nd Annual J.P. Morgan Healthcare Conference 8:29 a.m. Jan. 2, 2014 - BusinessWire
Presentation of Clinical Study Data, Prestigious Accolades, and Acquisitions - Research Report on Celgene, UnitedHealth, AstraZeneca, Mylan, and Valeant 8:00 a.m. Dec. 25, 2013 - PR Newswire
Clinical Study Data Presentation, Product Launches, Technology Deployments, and Stock Price Movements - Research Report on Celgene, Mylan, Valeant, Health Management, and CareFusion 8:00 a.m. Dec. 17, 2013 - PR Newswire
Atara Biotherapeutics Secures $38.5 Million Series B Financing 7:00 a.m. Dec. 17, 2013 - BusinessWire
Agios Advances Cancer Metabolism Collaboration with Celgene 8:16 a.m. Dec. 11, 2013 - BusinessWire
Studies Evaluating REVLIMID(R) (Lenalidomide) in Lymphoma Presented at ASH 7:00 p.m. Dec. 10, 2013 - BusinessWire
Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST(R)/IMNOVID(R) (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH 8:30 a.m. Dec. 10, 2013 - BusinessWire
REVLIMID(R) (lenalidomide)-Treated Patients with Deletion-5q MDS Who Achieve Transfusion-Independence of At Least 26 Weeks and AML-Free Survival Associated with Cytogenetic Response 7:30 p.m. Dec. 9, 2013 - BusinessWire
Stock Price Movements, Completed Acquisitions, and New Clinical Studies - Research Report on UnitedHealth Group, Mylan, St. Jude Medical, and Cigna 8:00 a.m. Dec. 9, 2013 - PR Newswire
First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk Myelodysplastic Syndromes Presented at ASH 9:37 p.m. Dec. 7, 2013 - BusinessWire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
OncoMed and Celgene Announce Strategic Collaboration Advancing Multiple Anti-Cancer Stem Cell Therapeutics to Offer Potential Benefits to Cancer Patients 7:30 a.m. Dec. 3, 2013 - GlobeNewswire
Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer 8:00 a.m. Nov. 28, 2013 - PR Newswire
Critical Alerts For American Express, Celgene, Altera, JC Penney, and Coach Released By InvestorsObserver 9:31 a.m. Nov. 25, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anavex Faces Fraud Suit: Key Details for Investors

A Crunch Point for Anavex Life Sciences Investors This ain't the kind of news you want hitting your ticker tape—Anavex Life Sciences Corp. (NASDAQ: AVXL) has been slapped with a securities fraud class action. The beef? Allegedly they made some less-than-stellar statements to their investors during a critical time frame. We're talking from November 26, 2025, to August...

Borussia Dortmund's Q1 2026/2027 Earnings Slip Amid Challenges

An Uneven Start to Borussia Dortmund's Financial Year Every finance year kickoff has its tales, and Borussia Dortmund's start for 2026/2027 is no different. The embattled team has been juggling a mixed bag of financial outcomes, darting through initial challenges with a revenue that hovers slightly above the previous year's mark. Revenue crept up to EUR 107.4 million,...

Ast?'s Strategy: Scaling Brands with Operator Insight

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

NativeSeed Group Expands with Sharp Brothers Buyout

A Quiet Giant Grows Stronger Who would've thought? While most folks are caught up watching tech stocks or energy commodities spike, NativeSeed Group just made a move worth raising an eyebrow over. On November 5, 2026, they scooped up the assets of Sharp Brothers Seed Company, a small firm in Healy, Kansas known for top-tier native seed cleaning. We've got ourselves a...

RadianX Grabs $9M for Perovskite Solar Push

RadianX Making Waves with New Funding Diving headfirst into the clean energy scene, RadianX has snagged a hefty $9 million in fresh funding. Now, this isn't some chump change. We're talking about a solid push to get their perovskite photovoltaic modules off the ground and into widespread use. They've got financial backing from big players like SOSV and Twynam, spearheaded...

APEC CEO Summit Marries Innovation and Global Ties

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Savor This Holiday: Apple Cinnamon Martinis Shine Bright

A Twist on Tradition for the Holidays Forget about slaving at the bar this holiday season because Rancho La Gloria's coming through with a real game-changer. They're rolling out their new Apple Cinnamon Martini just in time to take your holiday festivities up a notch or two. We're talking 13.9% ABV, folks. That's no sipper from a juice box—this cocktail's got backbone,...

Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

Drake Software Unleashes AI to Boost Tax Prep Efficiency

Tax time's approaching, and Drake Software's rolling out some high-octane solutions to keep tax professionals from drowning in paperwork. We're talking about AI innovations integrated right into the Drake Tax suite—an evolution that could shift the gears of tax prep massively. AI Revolution in Tax Preparedness Drake Software’s got some tricks up its sleeve for Tax...

Empower Brokerage Draws Talent to North Texas Job Fair

Shakeup at the North Texas Job Fair Slinging insurance ain't everyone's dream gig, but some folks find their calling where money meets meaning. The North Texas Job Fair, already known for its heavy foot traffic, saw a unique player strutting their stuff this year—Empower Brokerage. This family-owned insurance agency wasn't just slinging corporate pitch; they offered a...